Paper12152001
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans.
Eppler SM and 8 others. Clin Pharmacol Ther, 2002. Cited by 205 papers, by iCite.
Cite this record
ConductScience Library. A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Papers, record 12152001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12152001
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans.
- PubMed
- Publication types
- Clinical Trial, Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endothelial Growth Factors | Major topic |
| Hemodynamics | Major topic |
| Lymphokines | Major topic |
| Adult | |
| Aged | |
| Coronary Disease | |
| Coronary Vessels | |
| Female | |
| Half-Life | |
| Humans | |
| Infusions, Intravenous | |
| Injections, Intravenous | |
| Male | |
| Middle Aged | |
| Models, Biological | |
| Recombinant Proteins | |
| Vascular Endothelial Growth Factor A | |
| Vascular Endothelial Growth Factors |
Source PubMed
Cited by95
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 205 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42876988 | In Vitro Cell Proliferation, Osteogenic Differentiation, and In Vivo Angiogenesis Induced by Modified mRNA Encoding Vascular Endothelial Growth Factor-A. | Int J Dent | 2026 | https://conductscience.org/library/papers/42876988 | PubMed |
| 41807626 | The Effect of Controlled Release Mixture of VEGF165 and Fibrin Sealant on Flap Preconditioning in a Rat Perforator Island Flap Model. | Aesthetic Plast Surg | 2026 | https://conductscience.org/library/papers/41807626 | PubMed |
| 40951439 | Comparison of the efficacy of single vs. double autologous platelet-rich plasma intrauterine infusion on endometrial receptivity in thin endometrium patients: a prospective randomized controlled trial. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40951439 | PubMed |
| 40305554 | Falsifying computational models of endothelial cell network formation through quantitative comparison with in vitro models. | PLoS Comput Biol | 2025 | https://conductscience.org/library/papers/40305554 | PubMed |
| 39633684 | Engineering ADSCs by manipulating YAP for lymphedema treatment in a mouse tail model. | Exp Biol Med (Maywood) | 2024 | https://conductscience.org/library/papers/39633684 | PubMed |
| 38874518 | Posttranscriptional Modification to Modulate Progenitor Differentiation on Heterotypic Spheroids. | Tissue Eng Part A | 2024 | https://conductscience.org/library/papers/38874518 | PubMed |
| 37244975 | VEGF overexpressed mesoangioblasts enhance urethral and vaginal recovery following simulated vaginal birth in rats. | Sci Rep | 2023 | https://conductscience.org/library/papers/37244975 | PubMed |
| 36873982 | Vascular therapy for Duchenne muscular dystrophy (DMD). | Fac Rev | 2023 | https://conductscience.org/library/papers/36873982 | PubMed |
| 36873356 | Angiogenesis and Re-endothelialization in decellularized scaffolds: Recent advances and current challenges in tissue engineering. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/36873356 | PubMed |
| 36168632 | Targeted delivery of nanomedicines for promoting vascular regeneration in ischemic diseases. | Theranostics | 2022 | https://conductscience.org/library/papers/36168632 | PubMed |
| 36127472 | Nonclinical Pharmacokinetics, Pharmacodynamics, and Translational Model of RO7297089, A Novel Anti-BCMA/CD16A Bispecific Tetravalent Antibody for the Treatment of Multiple Myeloma. | AAPS J | 2022 | https://conductscience.org/library/papers/36127472 | PubMed |
| 36099430 | Protease-Sensitive, VEGF-Mimetic Peptide, and IKVAV Laminin-Derived Peptide Sequences within Elastin-Like Recombinamer Scaffolds Provide Spatiotemporally Synchronized Guidance of Angiogenesis and Neurogenesis. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/36099430 | PubMed |
| 35229250 | Modified Exosomes: a Good Transporter for miRNAs within Stem Cells to Treat Ischemic Heart Disease. | J Cardiovasc Transl Res | 2022 | https://conductscience.org/library/papers/35229250 | PubMed |
| 34640224 | Effect of Different Root Canal Irrigant Solutions on the Release of Dentin-Growth Factors: A Systematic Review and Meta-Analysis. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/34640224 | PubMed |
| 34479220 | miRNA induced co-differentiation and cross-talk of adipose tissue-derived progenitor cells for 3D heterotypic pre-vascularized bone formation. | Biofabrication | 2021 | https://conductscience.org/library/papers/34479220 | PubMed |
| 34068392 | The Prominin-1-Derived Peptide Improves Cardiac Function Following Ischemia. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34068392 | PubMed |
| 33977260 | Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study. | Brain Commun | 2020 | https://conductscience.org/library/papers/33977260 | PubMed |
| 33898634 | VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/33898634 | PubMed |
| 33775706 | Biologics and their delivery systems: Trends in myocardial infarction. | Adv Drug Deliv Rev | 2021 | https://conductscience.org/library/papers/33775706 | PubMed |
| 33746761 | Nano-Medicine in the Cardiovascular System. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/33746761 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12152001
GET https://conductscience.org/api/papers/v1/12152001/cited_by?page=2